InsiderClue
Insiders · Profile

ARSENAULT KAITLYN

Chief Financial Officer at Skye Bioscience. Filing since 15 Nov 2024. CIK 0001877242

Company
Date
Role
Action
Shares
Amount
Of holding
SKYE Skye Bioscience, Inc.
18 Nov 2024
Chief Financial Officer
Sold at will
43,206
$215.60K
20.6%
SKYE Skye Bioscience, Inc.
15 Nov 2024
Chief Financial Officer
Sold at will
190
$1.05K
0.1%
2 decisions on file.